State forced to stop discriminating against whites in COVID treatment - The Jewish Voice
88.9 F
New York
Friday, July 1, 2022

State forced to stop discriminating against whites in COVID treatment

- Advertisement -

Related Articles


Must read

Art Moore(WND NEWS CENTER) A lawsuit has forced Minnesota to align with Dr. Martin Luther King Jr.’s vision of a colorblind society and drop its discrimination against whites in the distribution of monoclonal antibody treatments for COVID-19.

The Star Tribune of Minneapolis reported Minnesota’s health department used a scoring system for prioritizing treatment that awarded two points to “BIPOC” people, meaning black, indigenous or people of color.

The removal of the racial formula came as the result of a lawsuit by the nonprofit America First Legal against Minnesota, Utah and New York.

The legal group’s general counsel, Gene Hamilton, said similar race-based health-care treatment that is being implemented across the country is “antithetical to everything we stand for as Americans.”

“And while the allocation of medical treatment based on skin color is not something any American would expect to see in 2022, the American people should understand that this is just another example of the application of ‘equity’ by the woke and radical left,” he said.

Hamilton told Minnesota Health Commissioner Jan Malcolm the policy violates Obamacare — the Affordable Care Act — among other federal laws.

“Rather than directing medical providers to assess underlying medical conditions that could heighten a patient’s risk of progression to severe COVID-19 — regardless of their race or ethnicity — your department lumps all non-White people into one monolithic block and makes blanket assertions about their underlying medical vulnerabilities,” Hamilton wrote.

The attorney said the policy “does not promote fairness across your population, it does not respect individuals, and it does not protect against inequity.”

“Instead, it subjects an entire class of citizens to unequal treatment based on the color of their skin.”

Minnesota officials argued the U.S. Food and Drug Administration advocated the policy in a fact sheet that was updated in December.

The FDA document said: “Other medical conditions or factors (for example, race or ethnicity) may also place individual patients at high risk for progression to severe COVID-19, and authorization of sotrovimab under the [emergency use authorization] is not limited to the medical conditions or factors listed above.”

New York state’s health department, meanwhile, discriminates against non-Hispanic white people in the distribution of oral antivirals, the Washington Times reported.

That policy amounts to “dividing New Yorkers by the color of their skin,” said Rep. Lee Zeldin, R-N.Y., who is vying to be the Republican nominee who will take on Democratic Gov. Kathy Hochul in this fall’s election.

Zeldin said he’s “heard from multiple constituents with qualifying health conditions who are concerned they have been denied because of this new order.”

Utah’s policy allows medical professionals to consider race and ethnicity when determining eligibility for monoclonal antibody treatments for COVID. Health officials argue Utahns “who identify from communities of color have a significantly higher risk of severe disease requiring hospitalization.”

Content created by the WND News Center is available for re-publication without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact

balance of natureDonate

Latest article

- Advertisement -
Skip to content